
Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency
Keywords: HCV NS5B پلیمراز; HCV NS5B polymerase; 2-Alkyl quinolone; 1,6-Naphthyridine-4,5-dione; Non-nucleoside inhibitor; Direct acting antiviral; Allosteric site;